ClinicalTrials.govpublic full text
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
hepatocellular carcinoma, liver cancer, hcc, mln0128, sapanisertib, torc1/2 inhibitor, ink128, nexavar, sorafenib, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880171
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.